Jun 21 |
Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds?
|
May 15 |
Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
|
May 15 |
Q1 2024 Acumen Pharmaceuticals Inc Earnings Call
|
May 14 |
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2024 Earnings Call Transcript
|
May 14 |
Acumen Pharmaceuticals GAAP EPS of -$0.25
|
May 14 |
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
|
May 13 |
Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
|
May 8 |
Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
|
May 8 |
Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease
|
May 7 |
Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024
|